1410 related articles for article (PubMed ID: 8640068)
1. Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions.
Steinbeck ZR; Heselmeyer KM; Gerlach B; Björnhagen V; Auer GU
Melanoma Res; 1996 Feb; 6(1):37-43. PubMed ID: 8640068
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
[TBL] [Abstract][Full Text] [Related]
4. DNA-cytophotometry of benign compound and intradermal naevi, Spitz epithelioid naevi and malignant melanomas.
Lindholm C; Bjelkenkrantz K; Hofer PA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(4):257-8. PubMed ID: 2890239
[TBL] [Abstract][Full Text] [Related]
5. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K
Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880
[TBL] [Abstract][Full Text] [Related]
6. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
[TBL] [Abstract][Full Text] [Related]
7. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
[TBL] [Abstract][Full Text] [Related]
8. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis.
Casorzo L; Luzzi C; Nardacchione A; Picciotto F; Pisacane A; Risio M
Melanoma Res; 2005 Jun; 15(3):155-60. PubMed ID: 15917696
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma--its precursors and its topography of proliferation. DNA-Feulgen-cytophotometry and mitosis index.
Schmiegelow P; Schroiff R; Breitbart E; Bahnsen J; Lindner J; Jänner M
Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):47-59. PubMed ID: 3085340
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
12. Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis.
Winer I; Normolle DP; Shureiqi I; Sondak VK; Johnson T; Su L; Brenner DE
Melanoma Res; 2002 Oct; 12(5):429-34. PubMed ID: 12394183
[TBL] [Abstract][Full Text] [Related]
13. Analysis of melanocytic lesions by DNA image cytometry.
Schmidt B; Weinberg DS; Hollister K; Barnhill RL
Cancer; 1994 Jun; 73(12):2971-7. PubMed ID: 8199994
[TBL] [Abstract][Full Text] [Related]
14. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity.
Li LX; Crotty KA; Scolyer RA; Thompson JF; Kril JJ; Palmer AA; McCarthy SW
Melanoma Res; 2003 Dec; 13(6):581-6. PubMed ID: 14646621
[TBL] [Abstract][Full Text] [Related]
15. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
16. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
[TBL] [Abstract][Full Text] [Related]
17. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
18. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
[TBL] [Abstract][Full Text] [Related]
19. The flow cytometry of melanocytic skin lesions.
Newton JA; Camplejohn RS; McGibbon DH
Br J Cancer; 1988 Nov; 58(5):606-9. PubMed ID: 3219270
[TBL] [Abstract][Full Text] [Related]
20. Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties.
Kanter L; Blegen H; Wejde J; Lagerlöf B; Larsson O
Melanoma Res; 1995 Oct; 5(5):345-50. PubMed ID: 8541725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
